Coronary angioplasty volume-outcome relationships for hospitals and cardiologists

E L Hannan1, M Racz, T J Ryan

  • 1State University of New York at Albany, 12144-3456, USA.

JAMA
|March 19, 1997
PubMed

Insights

Higher hospital and cardiologist volume for percutaneous transluminal coronary angioplasty (PTCA) is linked to better patient outcomes. Increased procedural volume is associated with lower in-hospital mortality and coronary artery bypass graft surgery rates.

Area of Science:

  • Cardiovascular Medicine
  • Health Services Research
  • Interventional Cardiology

Background:

  • Provider volume is a critical factor in healthcare quality.
  • Assessing the impact of hospital and cardiologist procedural volume on patient outcomes is essential for quality improvement.

Purpose of the Study:

  • To evaluate the association between annual hospital and cardiologist volume for percutaneous transluminal coronary angioplasty (PTCA).
  • To determine the relationship between PTCA volume and in-hospital mortality and same-stay coronary artery bypass graft (CABG) surgery rates.

Main Methods:

  • A cohort study utilizing data from the New York State Department of Health's Coronary Angioplasty Reporting System (1991-1994).
  • Included 62,670 patients undergoing PTCA across 31 hospitals in New York State.
  • Analyzed in-hospital mortality and same-stay CABG surgery rates as primary outcomes.

Main Results:

  • Overall in-hospital mortality was 0.90% and same-stay CABG rate was 3.43%.
  • Lower hospital PTCA volume (<600) was associated with significantly higher mortality (0.96%) and CABG rates (3.92%).
  • Lower cardiologist PTCA volume (<75) also showed significantly higher mortality (1.03%) and CABG rates (3.93%).

Conclusions:

  • Both hospital and cardiologist PTCA volume are significantly inversely related to in-hospital mortality and same-stay CABG surgery rates.
  • Higher procedural volumes for PTCA are associated with improved patient safety and outcomes.
  • Findings support the importance of volume-outcome relationships in interventional cardiology.
Abstract

Related Concept Videos

Cardiac Output and Stroke Volume01:11

Cardiac Output and Stroke Volume

Cardiac output (CO) is an integral aspect of human physiology, reflecting the heart's efficiency and responsiveness to the body's needs. It represents the volume of blood that the left or right ventricle ejects into the aorta or pulmonary trunk each minute. The CO is calculated by multiplying the heart rate (HR)—the number of heartbeats per minute—by the stroke volume (SV)—the amount of blood pumped out with each heartbeat.
In an average resting adult male, the typical cardiac output averages...
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...